Gorana Capkun

710 total citations
24 papers, 519 citations indexed

About

Gorana Capkun is a scholar working on Pathology and Forensic Medicine, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Gorana Capkun has authored 24 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Epidemiology and 4 papers in Economics and Econometrics. Recurrent topics in Gorana Capkun's work include Multiple Sclerosis Research Studies (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Gorana Capkun is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Gorana Capkun collaborates with scholars based in Switzerland, United States and Germany. Gorana Capkun's co-authors include Raquel Lahoz, Jonathan R. Korn, Neetu Agashivala, Charles Makin, Catherine B. McGuiness, Allison Petrilla, Swapna Karkare, Niklas Bergvall, Ashish Pradhan and Aoife Callan and has published in prestigious journals such as PLoS ONE, Neurology and Diabetes.

In The Last Decade

Gorana Capkun

24 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gorana Capkun Switzerland 12 267 123 78 75 73 24 519
Neetu Agashivala United States 14 414 1.6× 55 0.4× 102 1.3× 94 1.3× 101 1.4× 30 602
Michael W. Pill United States 9 285 1.1× 42 0.3× 24 0.3× 88 1.2× 92 1.3× 10 531
José M.A. Wijnands Canada 14 418 1.6× 66 0.5× 49 0.6× 47 0.6× 152 2.1× 25 612
Robert J. Barry United Kingdom 14 66 0.2× 70 0.6× 36 0.5× 46 0.6× 136 1.9× 41 758
Nicholas Adlard Switzerland 13 361 1.4× 28 0.2× 30 0.4× 64 0.9× 79 1.1× 46 524
Orhan Zengin Türkiye 14 74 0.3× 53 0.4× 62 0.8× 96 1.3× 103 1.4× 30 499
Hollie Schmidt United States 8 229 0.9× 24 0.2× 30 0.4× 53 0.7× 58 0.8× 20 413
Jessica B. Smith United States 12 247 0.9× 38 0.3× 41 0.5× 67 0.9× 23 0.3× 18 465
Charlotte Brierley United Kingdom 14 102 0.4× 54 0.4× 185 2.4× 61 0.8× 35 0.5× 25 672
Caroline Kelley United States 8 109 0.4× 87 0.7× 28 0.4× 28 0.4× 43 0.6× 16 439

Countries citing papers authored by Gorana Capkun

Since Specialization
Citations

This map shows the geographic impact of Gorana Capkun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gorana Capkun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gorana Capkun more than expected).

Fields of papers citing papers by Gorana Capkun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gorana Capkun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gorana Capkun. The network helps show where Gorana Capkun may publish in the future.

Co-authorship network of co-authors of Gorana Capkun

This figure shows the co-authorship network connecting the top 25 collaborators of Gorana Capkun. A scholar is included among the top collaborators of Gorana Capkun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gorana Capkun. Gorana Capkun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schattenberg, Jörn M., Maria‐Magdalena Balp, B.S. Reinhart, et al.. (2023). NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings. Scientific Reports. 13(1). 5573–5573. 7 indexed citations
2.
Capkun, Gorana, Cláudia Furtado, Páll Jónsson, et al.. (2022). Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?. International Journal of Technology Assessment in Health Care. 38(1). e79–e79. 14 indexed citations
3.
Régnier, Stéphane A., Gorana Capkun, Maria‐Magdalena Balp, et al.. (2021). Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis. Journal of the American Medical Informatics Association. 28(6). 1235–1241. 32 indexed citations
4.
Karcher, Hélène, et al.. (2020). Modelling Decline in Cognition to Decline in Function in Alzheimer’s Disease. Current Alzheimer Research. 17(7). 635–657. 4 indexed citations
5.
Tietz, Andreas, Stéphane A. Régnier, Maria‐Magdalena Balp, et al.. (2020). 1487-P: Increased Identification of NASH among Diabetic and Nondiabetic Patients through Machine Learning in Real-World Settings. Diabetes. 69(Supplement_1). 1 indexed citations
6.
Capkun, Gorana, et al.. (2019). Development and validation of a Bayesian survival model for inclusion body myositis. Theoretical Biology and Medical Modelling. 16(1). 17–17. 2 indexed citations
7.
Régnier, Stéphane A., et al.. (2019). PDB125 PREDICTING NASH PATIENTS USING INNOVATIVE MACHINE LEARNING TECHNIQUES. Value in Health. 22. S595–S595. 1 indexed citations
8.
Capkun, Gorana, Frank Dahlke, Raquel Lahoz, et al.. (2015). Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. Multiple Sclerosis and Related Disorders. 4(6). 546–554. 90 indexed citations
9.
Thom, Howard, Gorana Capkun, Annamaria Cerulli, Richard M. Nixon, & Luke Howard. (2015). Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension. BMC Medical Research Methodology. 15(1). 34–34. 28 indexed citations
10.
Capkun, Gorana, Raquel Lahoz, E. Verdun, et al.. (2015). Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis. Current Medical Research and Opinion. 31(5). 1029–1039. 25 indexed citations
11.
Rothenbacher, Dietrich, et al.. (2015). New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis. Current Medical Research and Opinion. 31(5). 953–965. 8 indexed citations
12.
Thom, Howard, Gorana Capkun, Richard M. Nixon, & Alberto Ferreira. (2014). Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion. BMC Medical Research Methodology. 14(1). 140–140. 8 indexed citations
13.
Bergvall, Niklas, Allison Petrilla, Swapna Karkare, et al.. (2014). Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis. Journal of Medical Economics. 17(10). 696–707. 79 indexed citations
14.
Bergvall, Niklas, Charles Makin, Raquel Lahoz, et al.. (2014). Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study. PLoS ONE. 9(2). e88472–e88472. 58 indexed citations
15.
Lahoz, Raquel, Niklas Bergvall, Neetu Agashivala, et al.. (2014). Relapse Rates Among Patients With Multiple Sclerosis Who Switch From Interferon Therapy To Fingolimod Or Glatiramer Acetate: A Retrospective US Claims Database Analysis (P7.211). Neurology. 82(10_supplement). 6 indexed citations
16.
Bergvall, Niklas, Charles Makin, Raquel Lahoz, et al.. (2013). Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis. Current Medical Research and Opinion. 29(12). 1647–1656. 35 indexed citations
17.
Altpeter, Ekkehardt, Bernard Burnand, Gorana Capkun, et al.. (2005). Essentials of good epidemiological practice. Sozial- und Präventivmedizin. 50(1). 12–15. 20 indexed citations
18.
Capkun, Gorana, et al.. (2005). Trends in primary care consultations for asthma in Switzerland, 1989–2002. International Journal of Epidemiology. 34(5). 1012–1018. 8 indexed citations
19.
Schaub, L., Sylvain Sardy, & Gorana Capkun. (2002). Natural variation in baseline data: when do we call a new sample ‘resistant’?. Pest Management Science. 58(9). 959–963. 14 indexed citations
20.
Capkun, Gorana, A. C. Davison, & A. Musy. (2001). A robust rainfall‐runoff transfer model. Water Resources Research. 37(12). 3207–3216. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neetu Agashivala Breakdown of academic impact, for papers by Michael W. Pill Breakdown of academic impact, for papers by José M.A. Wijnands Breakdown of academic impact, for papers by Robert J. Barry Breakdown of academic impact, for papers by Nicholas Adlard Breakdown of academic impact, for papers by Orhan Zengin Breakdown of academic impact, for papers by Hollie Schmidt Breakdown of academic impact, for papers by Jessica B. Smith Breakdown of academic impact, for papers by Charlotte Brierley Breakdown of academic impact, for papers by Caroline Kelley
Rankless by CCL
2026